Citation Impact
66 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Bispecific antibodies: advancing precision oncology
2024 Standout
Works of Shaojun Lin being referenced
436 A phase II study of AK104, a bispecific antibody targeting PD-1 and CTLA-4, in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy
2021
Author Peers
| Author | Otorhinolaryngology | Oncology | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Shaojun Lin | 878 | 510 | 573 | 62 | 1.3k | |
| Barbara A. Lutey | 9 | 23 | 11 | 449 | ||
| Hammam Soliman | 1 | 8 | 299 | |||
| Xiaodan Li | 10 | 5 | 22 | 458 | ||
| Lene Haugaard Mikkelsen | 2 | 1 | 13 | 880 | ||
| Elias Dagnew | 6 | 45 | 145 | 11 | 432 |
All Works
Loading papers...